Expert Video Report on the Management of Breast Cancer

ESMO 2018 Congress

Speaker: Alessandra Gennari

Commenting on the findings from IMpassion130 and SOLAR-1 trials presented at ESMO 2018 Congress, Dr Alessandra Gennari says that these two important study results will change the treatment of Advanced Breast Cancer.
In conclusion, the results show that we can improve the prognosis of metastatic Breast Cancer either in Triple Negative disease with immunotherapy, or in ER+ disease with a new Pi3K inhibitor which appears to be less toxic than previously developed coumpounds.

ESMO 2018 Congress abstracts: